All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
The development and manufacture of high-quality plasmid DNA for Chimeric Antigen Receptor T-cell (CART) therapy are critical due to the therapy's targeted and systemic nature. In the continually evolving field of genetic engineering, ensuring the quality, purity, and scalability of plasmid DNA is paramount. With decades of experience, Creative Biolabs facilitates advanced, research-grade plasmid DNA manufacturing techniques tailored for CART applications.
The use of Research Grade (RG) plasmid DNA is crucial for the development and optimization of CART therapies. Creative Biolabs specializes in producing plasmids that are integral for preclinical studies and initial proof-of-concept experiments. Our RG plasmid DNA is consistently high in purity, tailored to meet the specific needs of our clients, and is manufactured using proprietary processes that ensure rapid turnaround without compromising on quality.
Creative Biolabs offers a comprehensive suite of services for RG plasmid DNA manufacturing, designed to support a wide range of experimental needs:
Plasmid Engineering and OptimizationTailor-made DNA plasmid sequences designed for optimal expression and functionality in CART applications.
From microgram to gram scales, our facilities are equipped to handle varying production scales to match project requirements.
Using advanced chromatographic techniques to achieve high purity levels with minimal endotoxin content.
Rigorous quality control measures are applied at every stage of production to ensure the highest standards are maintained.
Ensuring the quality and consistency of RG plasmid DNA is paramount for the success of CART therapies. At Creative Biolabs, our quality control protocols include:
Every batch undergoes thorough visual analysis to detect any inconsistencies or contaminants.
Nanodrop technology is employed to accurately determine plasmid concentration.
Endotoxin levels are quantified using kinetic chromogenic LAL assays to meet stringent regulatory standards (<0.05 EU/μg for RG grade).
Agarose gel electrophoresis is used to ensure high proportions of supercoiled plasmid forms, essential for effective CART transfection.
Sanger sequencing or Next-Generation Sequencing (NGS) are available options for confirming plasmid identity and integrity.
Creative Biolabs' services stand out due to several key advantages:
Q1: How do you ensure the purity of RG plasmid DNA?
A1: Creative Biolabs utilizes a combination of selective precipitation, advanced chromatographic purification, and rigorous quality control measures to ensure the highest levels of plasmid purity. Every batch undergoes thorough testing to verify purity.
Q2: Can you handle large-scale plasmid production?
A2: Yes, our facilities are equipped to scale production from micrograms to multi-gram quantities, accommodating the needs of larger preclinical and research projects.
Creative Biolabs remains dedicated to advancing the field of CART therapies through the provision of high-quality Research Grade (RG) plasmid DNA. Our extensive expertise, state-of-the-art facilities, and commitment to excellence enable us to support cutting-edge research and development projects, driving innovation and improving therapeutic outcomes in the fight against cancer.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION